Surgical sutures of unsymmetrically substituted 1,4-dioxane-2,5-

Surgery – Truss – Pad

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61L 1700

Patent

active

039601528

ABSTRACT:
Unsymmetrically 3,6-substituted 1,4-dioxane-2,5-diones may be polymerized to give living-tissue absorbable, hydrolytically degradable surgically useful polymers. These polymers have predominantly regular rather than random spacings of side chains, may be stereoregular and tend toward higher crystallinity than randomly sequenced polymers. A polymer of 3-methyl-1,4-dioxane-2,5-dione has the same empirical formula as an equimolecular copolymer of lactic and glycolic acid but has unique physical properties resulting from its more regular steric configuration. Polymers and copolymers of 3- and 3,6-unsymmetrically substituted 1,4-dioxane-2,5-diones have surgically useful mechanical properties. On implantation, in living mammalian tissue, the polymers are absorbed, and replaced by living tissue.

REFERENCES:
patent: 3755558 (1973-08-01), Scribner
patent: 3772420 (1973-11-01), Glick et al.
patent: 3773737 (1973-11-01), Goodman et al.
patent: 3778476 (1973-12-01), Rembaum et al.
patent: 3839297 (1974-10-01), Wasserman et al.
patent: 3883901 (1975-05-01), Coquard et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Surgical sutures of unsymmetrically substituted 1,4-dioxane-2,5- does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Surgical sutures of unsymmetrically substituted 1,4-dioxane-2,5-, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Surgical sutures of unsymmetrically substituted 1,4-dioxane-2,5- will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2399282

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.